de Oliveira, Jose Mario Franco <br/><br/>
Utility of GLP-1R agonists in diabetes requires long term study.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Feb 2012 
 - e1451; author reply e1459 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.e1451  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Obesity Agents--therapeutic use<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Overweight--drug therapy<br/>Peptides--therapeutic use<br/>Receptors, Glucagon--agonists<br/>Venoms--therapeutic use<br/>Weight Loss--drug effects